Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

Basilea’s Hans Christian Rohde takes up commercial role at uniQure

Will serve as gene therapy specialist's chief commercial officer

Dr Reddy’s appoints Umang Vohra to lead US business

Will be replaced as chief financial officer by Saumen Chakraborty

GlobalCom welcomes Firstlight to its PR network

Agency replaces Pegasus PR as UK representative

Stephen Whitehead appointed HCA president

ABPI head joins comms association as exec committee is reorganised

- PMLiVE

Lilly taps Strides Arcolab for cancer generics

Aims to expand its presence in emerging pharmaceutical markets

- PMLiVE

BMS cuts Orencia price to win NICE over

Draft guidance now backs drug for earlier stage of rheumatoid arthritis treatment

- PMLiVE

Pfizer reports strong data with new breast cancer candidate

Phase II results suggest progression-free survival benefits for PD-0332991

- PMLiVE

Novo launches haemophilia tracking app

Will compete with similar apps from Pfizer, Baxter

- PMLiVE

Healthwatch England names Katherine Rake as director

Former advisor to Prime Minister will lead body to give patients in England a say in health policy

UK flag

UK budget 2012: Industry welcomes £600m for science research

Chancellor also makes new cut in corporation tax and plans next steps to support life sciences

- PMLiVE

Cromsource appoints Dr Christian Milla to head-up medical division

He will also serve as the Italian CRO's French country manager

- PMLiVE

One man’s junk: What non-coding DNA means for pharma

ENCODE has identified 400 regions of ‘junk’ or non-coding DNA that may have a bearing on disease states, and the implications for pharma and patients are huge

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links